Try our Advanced Search for more refined results
Health
-
March 11, 2026
Wash. Says ICE Contractor Cannot Defend Barring Inspection
The Washington State Department of Health said a contractor's attempts to escape an evidentiary hearing demonstrated that the company could not defend its jurisdictional claims in a lawsuit accusing it of illegally restricting access to an immigration facility.
-
March 11, 2026
Allstate Says Chiropractors Ran 'Personal Injury Mill'
Allstate told a Texas federal court in a lawsuit seeking at least $25.8 million that two chiropractors and their associated healthcare entities operated a racketeering enterprise to make money from automobile accident personal injury settlements.
-
March 11, 2026
Insulin Makers Ask Justices To Review Collusion Case
Sanofi-Aventis US, Eli Lilly & Co., Novo Nordisk Inc. and AstraZeneca Pharmaceuticals LP have told the U.S. Supreme Court that a ruling reviving a case over insulin drug costs undermines key rules meant to weed out improper antitrust claims.
-
March 11, 2026
Pharma Co. Says Ex-Director Using Trade Secrets At New Job
A specialty infusion therapy pharmacy has accused a former director of contracts of taking valuable trade secrets with her on her way out to work for a rival company.
-
March 11, 2026
VA, DOJ Cut Deal To Make Attys Mental Health Guardians
Under a new initiative, attorneys at the U.S. Department of Justice will serve as legal guardians for some homeless veterans, the Trump administration announced on Wednesday, though some veterans advocates expressed concern that the new program could involuntarily coerce veterans experiencing mental health issues into institutional care.
-
March 11, 2026
Pa. Justices Hint 3rd Jury Should Decide Misdiagnosis Case
The Pennsylvania Supreme Court on Wednesday appeared skeptical of an oncologist's argument that she should not have to face a third trial in a suit accusing her of treating a now-deceased woman for the wrong type of cancer, suggesting that disputed facts about the patient's care make the case suitable for a jury.
-
March 11, 2026
Pa. Justices Doubtful Law Unclear In AG-DA Opioid Deal Row
Multiple Pennsylvania Supreme Court justices on Wednesday doubted a state law was ambiguous about whether the attorney general could step in and settle claims brought by county-level district attorneys, as he had in a multistate settlement with opioid companies.
-
March 11, 2026
Minn. Lawmakers Advance Medical Psilocybin Bill
Minnesota lawmakers this week advanced a bipartisan bill to create a regulated medical program for psilocybin, the active ingredient in psychoactive mushrooms.
-
March 11, 2026
SEC Avoids Sanctions As Court Ends Unregistered Dealer Suit
A Minnesota federal judge denied financial firm Carebourn Capital's request for sanctions against the U.S. Securities and Exchange Commission and dismissed the agency's suit, which claims that Carebourn, its founder and an affiliated company made millions by selling securities as unregistered dealers.
-
March 11, 2026
Union Claims NJ Hospital Broke State Law In Layoffs
An American Federation of State, County and Municipal Employees local has accused a New Jersey hospital of violating state law by abruptly closing most of its facility in November without giving proper notice, in a complaint in New Jersey state court.
-
March 11, 2026
Biomedical Co. Settles Trade Secrets Case Against Ex-Worker
Biomedical company Skye Orthobiologics and a former employee have informed a California federal judge that they have settled a case accusing the ex-employee of breaching fiduciary duties by leveraging Skye's proprietary information.
-
March 11, 2026
Coalition Pushes For Ruling To Nix State Dept. Visa Pause
Nonprofit groups, U.S. citizens and foreign workers asked a New York federal judge to overturn a U.S. Department of State decision to pause the issuance of immigrant visas for people from 75 countries as unlawful overreach.
-
March 11, 2026
Hospital Revenue Co. Not Covered In $8M Loss Suit, AIG Says
An AIG unit said it has no duty to defend or indemnify a management company accused of causing $8 million in losses to a South Carolina nonprofit hospital system, telling a Texas federal court that the company knew about the losses before its policy's inception.
-
March 11, 2026
6th Circ. Upholds Ax Of Hospital Security Guard's Wage Suit
A former security guard for a Tennessee hospital did not plausibly allege that lunch periods were compensable work time under federal wage law, the Sixth Circuit ruled, affirming the dismissal of his proposed class action claiming that automatic deductions for meal breaks cost him overtime pay.
-
March 11, 2026
Aetna Will Pay $117.7M To Resolve False Billing Suit
Aetna Inc. has agreed to pay $117.7 million to settle claims that the company violated the False Claims Act by submitting, and failing to correct, false diagnosis codes for its Medicare Advantage plan customers in order to boost cash flow from the federal insurance program, the U.S. attorney's office in Philadelphia said Wednesday.
-
March 10, 2026
Wash. Justices Seem Open To Palestinian's Racial Bias Claim
The Washington State Supreme Court appeared somewhat receptive on Tuesday to a Palestinian patient's argument that an unfavorable jury verdict in her medical malpractice trial was tainted by racism, with several justices concerned that the defense had described the accused doctor as "from this part of the world" during openings.
-
March 10, 2026
UnitedHealth Must Reveal Nitty-Gritty In Claim Denial AI Case
A Minnesota federal judge has ordered UnitedHealth Group to hand over discovery on the secretive algorithm it uses to manage Medicare Advantage claims, ruling Monday that the insurer must disclose internal records detailing whether the technology was designed to override the clinical judgment of doctors.
-
March 10, 2026
Sanofi Says Judge Botched Insulin Device Patent Listings
Sanofi-Aventis sparred with drug wholesalers over a Massachusetts federal magistrate judge's pronouncements that the parties should go to trial on claims the pharmaceutical giant used improper insulin device patent listings to anticompetitively protect the blockbuster Lantus insulin pen from competition.
-
March 10, 2026
Lab's Aetna Payment Suit Survives, But With Deep Cuts
A Connecticut federal judge ruled Aetna and its parent company, CVS Health Corp., must face a pared down lawsuit from a medical laboratory alleging it is owed $20.6 million in unpaid invoices.
-
March 10, 2026
FDA To Consider Coffee, 'Spice' E-Cig Flavors
The U.S. Food and Drug Administration on Monday indicated that it would be willing to consider e-cigarette flavors shown to be less attractive to youth, like coffee or spices, a move that's come under fire from public health advocates.
-
March 10, 2026
Wash. To Set Its Own Vaccine Schedule Under New State Law
Washington Gov. Bob Ferguson has signed legislation that requires health plans to cover vaccines and other preventive care recommended by the state rather than the federal government, joining a movement toward states setting their own recommendations.
-
March 10, 2026
4th Circ. Backs W.Va.'s Trans Care Coverage Exclusion
The Fourth Circuit said Tuesday that West Virginia's Medicaid coverage exclusion for gender-affirming care passes constitutional muster and does not discriminate based on sex, basing its conclusion on a U.S. Supreme Court ruling that upheld Tennessee's ban on gender-affirming care for minors.
-
March 10, 2026
CVS Can't 'Relitigate' Price-Gouging Class Cert.
A Rhode Island federal judge refused to narrow the certified classes of health plans alleging CVS schemed with pharmacy benefit managers to overcharge insured health plans for generic drugs, finding that PBM Express Scripts' refusal to produce its contracts changes nothing about how the classes will be assessed.
-
March 10, 2026
2nd Circ. Revives Geico's Suit Over Acupuncture Referrals
A lower court erred in granting summary judgment to Geico after the insurer sued over reimbursements to an acupuncturist involved in what Geico said was a kickback scheme, the Second Circuit ruled Tuesday, finding the district court misinterpreted a state law detailing requirements for referrals and no-fault payments.
-
March 10, 2026
Liberty Mutual Says Mich. Clinics Ran RICO Billing Scheme
Liberty Mutual has sued a group of Michigan medical providers, a physician and related businesses, claiming the collective ran a coordinated no-fault billing scheme that steered auto accident patients through affiliated providers to generate unnecessary medical bills.
Expert Analysis
-
11th Circ. May Bring Tectonic Shift To FCA Qui Tam Actions
The Eleventh Circuit's upcoming decision in Zafirov v. Florida Medical Associates, assessing whether the False Claims Act permits ordinary citizens to stand as officers of the federal government, could significantly limit private relators' ability to bring FCA actions, say attorneys at Saul Ewing.
-
AI-Generated Doc Ruling Guides Attys On Privilege Risks
A New York federal court's ruling, in U.S. v. Heppner, that documents created by a defendant using an artificial intelligence tool were not privileged, can serve as a guide to attorneys for retaining attorney-client or work-product privilege over client documents created with AI, say attorneys at Sher Tremonte.
-
To Survive FCA Actions, Small Cos. Must Take Offensive Steps
A fumbled response to False Claims Act allegations can doom lower-middle-market businesses, and with FCA enforcement hitting record levels for two years, smaller companies must have offensive strategies ready that focus their limited resources on defeating civil qui tam and federal criminal actions, says Derrelle Janey at Olshan Frome.
-
The Law Firm Merger Diaries: Leadership Strategy After Day 1
For law firm leaders, ensuring a newly combined law firm lives up to its promise, both in its first days of operation and well after, includes tough decisions, clear and specific communication, and cheerleading, says Peter Michaud at Ballard Spahr.
-
How US Liability Law Is Becoming The Primary Regulator Of AI
Comprehensive federal AI regulation remains fragmented and uncertain — but U.S. courts, applying long-standing doctrines of liability and responsibility, are actively shaping how AI systems are designed, deployed and governed, and companies are aligning their AI practices because courts may hold them accountable if they do not, says Alexander Lima at Wesco International.
-
Record FCA Recoveries Signal Intensified Healthcare Focus
In its recently released False Claims Act statistics, the U.S. government's emphasis on record healthcare recoveries and government-initiated healthcare matters last year indicates robust enforcement ahead, though the administration's focus on current policy objectives also extends beyond the healthcare sector, say attorneys at Epstein Becker.
-
Fed. Circ. In Jan.: On The Validity Of Expert Testimony
The Federal Circuit's recent decision in Barry v. DePuy, addressing whether expert testimony is admissible even if it does not strictly adhere to the court's claim construction, suggests that exclusion via a Daubert motion is appropriate only when the line to improper testimony is clearly crossed, say attorneys at Knobbe Martens.
-
Methods For Challenging State Civil Investigative Demands
Ongoing challenges to enforcement actions underscore the uphill battle businesses face in arguing that a state investigation is prohibited by federal law, but when properly deployed, these arguments present a viable strategy to resist civil investigative demands issued by state attorneys general, say attorneys at Troutman Pepper.
-
Calif.'s Civility Push Shows Why Professionalism Is Vital
The California Bar’s campaign against discourteous behavior by attorneys, including a newly required annual civility oath, reflects a growing concern among states that professionalism in law needs shoring up — and recognizes that maintaining composure even when stressed is key to both succeeding professionally and maintaining faith in the legal system, says Lucy Wang at Hinshaw.
-
A Potential Shift In FDA's Approach To Drug Trial Design
Recent guidance released by the U.S. Food and Drug Administration clarifying how Bayesian approaches — which combine prior knowledge with new data — may be used in clinical trials reflects the agency's continued interest in innovative trial designs that may accelerate drug approvals, say attorneys at Alston & Bird.
-
Opinion
SNAP Rule Confusion Risks A Compliance Crisis
Recent Supplemental Nutrition Assistance Program food restriction waivers pose a compliance crisis for legal practitioners advising food retailers, amid higher costs and lack of a coherent national standard, says Tyson-Lord Gray at Yeshiva University’s Benjamin N. Cardozo School of Law.
-
Series
Trivia Competition Makes Me A Better Lawyer
Playing trivia taught me to quickly absorb information and recognize when I've learned what I'm expected to know, training me in the crucial skills needed to be a good attorney, and reminding me to be gracious in defeat, says Jonah Knobler at Patterson Belknap.
-
What FDA Guidance Means For Future Of Health Software
Two significant final guidance documents released by the U.S. Food and Drug Administration last month reflect a targeted effort to ease innovation friction around specific areas, including singular clinical decision support recommendations and sensor-based wearables, while maintaining established regulatory boundaries, say attorneys at Covington.
-
Opinion
Federal Preemption In AI And Robotics Is Essential
Federal preemption offers a unified front at a decisive moment that is essential for safeguarding America's economic edge in artificial intelligence and robotics against global rivals, harnessing trillions of dollars in potential, securing high-skilled jobs through human augmentation, and defending technological sovereignty, says Steven Weisburd at Shook Hardy.
-
Series
Law School's Missed Lessons: What Cross-Selling Truly Takes
Early-career attorneys may struggle to introduce clients to practitioners in other specialties, but cross-selling becomes easier once they know why it’s vital to their first years of practice, which mistakes to avoid and how to anticipate clients' needs, say attorneys at Moses & Singer.